Fukuda S, Koshiura R, Miyamoto K, Hatano M
Gan. 1977 Apr;68(2):175-82.
Antitumor activity of 1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide (CAP-2) was studied in vivo and in vitro, using various rat ascites hepatoma cell lines. Among eight ascites hepatoma cell lines, AH-13 was extremely sensitive both to in vivo antitumor and to in vitro lethal action of the agent, whereas AH-44 was resistant in both cases. The sensitivity of ascites hepatoma cell lines to CAP-2, nitrogen mustard N-oxide, 4-nitroquinoline 1-oxide, and ultraviolet ray in vitro was widely different but their relative sensitivities were very similar against these agents. For all the agents, AH-13 was inactivated very rapidly and AH-109A moderately, whereas AH-44 was relatively resistant. These results indicate that the sensitivity of the cells to CAP-2 may be closely related to their repair-capability of damaged DNA. Similar experiments using various DNA repair-deficient mutants of Escherichia coli B strain demonstrated that the repair-deficient mutants were several times more sensitive to CAP-2 than the wild type strain. From these results, it may be concluded that CAP-2 induces DNA lesions repairable by the same repair mechanisms that work on pyrimidine dimers.
使用多种大鼠腹水肝癌细胞系,对1-(γ-氯丙基)-2-氯甲基哌啶氢溴酸盐(CAP-2)的抗肿瘤活性进行了体内和体外研究。在八种腹水肝癌细胞系中,AH-13对该药物的体内抗肿瘤作用和体外致死作用均极为敏感,而AH-44在这两种情况下均具有抗性。腹水肝癌细胞系对CAP-2、氮芥N-氧化物、4-硝基喹啉1-氧化物和紫外线的体外敏感性差异很大,但它们对这些药物的相对敏感性非常相似。对于所有这些药物,AH-13失活非常迅速,AH-109A中度失活,而AH-44相对抗性较强。这些结果表明,细胞对CAP-2的敏感性可能与其受损DNA的修复能力密切相关。使用大肠杆菌B株的各种DNA修复缺陷突变体进行的类似实验表明,修复缺陷突变体对CAP-2的敏感性比野生型菌株高几倍。从这些结果可以得出结论,CAP-2诱导的DNA损伤可通过与作用于嘧啶二聚体的相同修复机制进行修复。